Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Nov;35(11):2419–2422. doi: 10.1128/aac.35.11.2419

Plasmid-mediated ROB-1 beta-lactamase in Pasteurella multocida from a human specimen.

A Rosenau 1, A Labigne 1, F Escande 1, P Courcoux 1, A Philippon 1
PMCID: PMC245396  PMID: 1804018

Abstract

A Pasteurella multocida human isolate was resistant to beta-lactams because of production of ROB-1 beta-lactamase. The beta-lactamase was encoded by a 4.3-kb plasmid closely related to that of a Pasteurella bovine strain, as shown by Sau3A restriction profile and hybridization with a plasmid probe containing the blaROB-1 gene.

Full text

PDF
2421

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Haghour R., Hellmann E., Schmidt J. Plasmids and resistance to 9 chemotherapeutic agents of Pasteurella multocida and Pasteurella haemolytica. Epidemiological aspects. Zentralbl Veterinarmed B. 1987 Sep;34(7):509–518. doi: 10.1111/j.1439-0450.1987.tb00427.x. [DOI] [PubMed] [Google Scholar]
  2. Levesque R. C., Medeiros A. A., Jacoby G. A. Molecular cloning and DNA homology of plasmid-mediated beta-lactamase genes. Mol Gen Genet. 1987 Feb;206(2):252–258. doi: 10.1007/BF00333581. [DOI] [PubMed] [Google Scholar]
  3. Livrelli V. O., Darfeuille-Richaud A., Rich C. D., Joly B. H., Martel J. L. Genetic determinant of the ROB-1 beta-lactamase in bovine and porcine Pasteurella strains. Antimicrob Agents Chemother. 1988 Aug;32(8):1282–1284. doi: 10.1128/aac.32.8.1282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Medeiros A. A., Levesque R., Jacoby G. A. An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b. Antimicrob Agents Chemother. 1986 Feb;29(2):212–215. doi: 10.1128/aac.29.2.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Philippon A., Joly B., Reynaud D., Paul G., Martel J. L., Sirot D., Cluzel R., Névot P. Characterization of a beta-lactamase from Pasteurella multocida. Ann Inst Pasteur Microbiol. 1986 Mar-Apr;137A(2):153–158. doi: 10.1016/s0769-2609(86)80020-5. [DOI] [PubMed] [Google Scholar]
  6. Rubin L. G., Medeiros A. A., Yolken R. H., Moxon E. R. Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet. 1981 Nov 7;2(8254):1008–1010. doi: 10.1016/s0140-6736(81)91214-9. [DOI] [PubMed] [Google Scholar]
  7. Schmidt E. C., Truitt L. V., Koch M. L. Pulmonary abscess with empyema caused by Pasteurella multocida. Report of a fatal case. Am J Clin Pathol. 1970 Nov;54(5):733–736. doi: 10.1093/ajcp/54.5.733. [DOI] [PubMed] [Google Scholar]
  8. Stevens D. L., Higbee J. W., Oberhofer T. R., Everett E. D. Antibiotic susceptibilities of human isolates of Pasteurella multocida. Antimicrob Agents Chemother. 1979 Sep;16(3):322–324. doi: 10.1128/aac.16.3.322. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES